Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-61,843
Closed -$3.83M 342
2020
Q4
$3.83M Sell
61,843
-477
-0.8% -$27K 0.02% 183
2020
Q3
$3.22M Sell
62,320
-896
-1% -$49.9K 0.02% 182
2020
Q2
$3.45M Sell
63,216
-14,179
-18% -$804K 0.03% 168
2020
Q1
$4.7M Buy
77,395
+31,631
+69% +$2.39M 0.04% 136
2019
Q4
$3.71M Buy
45,764
+40,607
+787% +$3.36M 0.03% 172
2019
Q3
$451K Hold
5,157
﹤0.01% 312
2019
Q2
$429K Buy
+5,157
New +$424K ﹤0.01% 315

Other funds holding ALE

Bahl & Gaynor's ALE Position: Q1 2021 in Review

Bahl & Gaynor sold out of Allete (ALE) in Q1 2021, closing a stake of 61,843 shares — an estimated $3.83M sold.

Bahl & Gaynor first reported a position in ALE in Q2 2019 and held it in 7 quarters. The position peaked at $4.7M in Q1 2020. 270 funds tracked by Wall St. Rank hold ALE as of Q1 2021.

  • Bahl & Gaynor reported no remaining Allete position as of Q1 2021 after selling out during the quarter.
  • Bahl & Gaynor sold 61,843 Allete shares in Q1 2021, an estimated $3.83M.
  • Bahl & Gaynor first reported a position in Allete in Q2 2019 and held it in 7 quarters.
  • Bahl & Gaynor's Allete position peaked at $4.7M in Q1 2020.
  • 270 funds tracked by Wall St. Rank held Allete as of Q1 2021.

Based on Bahl & Gaynor's 13F filing for Q1 2021, filed 11 May 2021.